Advanced search
Publication Cover
Acta Oncologica Volume 41, 2002 - Issue 7-8
Journal homepage
374
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Cytotoxic Treatment of Aggressive Prostate Tumors with or without Neuroendocrine Elements

Gunnar Steineck From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine (G. Steineck, W.K. Kelly, R. Frank, H.I. Scher), the Departments of Pathology (V. Reuter) and Radiology (L. Schwartz), Memorial Sloan Kettering Cancer Center, New York, Clinical Cancer Epidemiology, Department of Oncology Pathology (G. Steineck), Karolinska Institutet, Stockholm, Sweden, Department of Medicine (W.K. Kelly, H.I. Scher), Cornell University Medical College, New York
,
Victor Reuter From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine (G. Steineck, W.K. Kelly, R. Frank, H.I. Scher), the Departments of Pathology (V. Reuter) and Radiology (L. Schwartz), Memorial Sloan Kettering Cancer Center, New York, Clinical Cancer Epidemiology, Department of Oncology Pathology (G. Steineck), Karolinska Institutet, Stockholm, Sweden, Department of Medicine (W.K. Kelly, H.I. Scher), Cornell University Medical College, New York
,
William K. Kelly From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine (G. Steineck, W.K. Kelly, R. Frank, H.I. Scher), the Departments of Pathology (V. Reuter) and Radiology (L. Schwartz), Memorial Sloan Kettering Cancer Center, New York, Clinical Cancer Epidemiology, Department of Oncology Pathology (G. Steineck), Karolinska Institutet, Stockholm, Sweden, Department of Medicine (W.K. Kelly, H.I. Scher), Cornell University Medical College, New York
,
Richard Frank From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine (G. Steineck, W.K. Kelly, R. Frank, H.I. Scher), the Departments of Pathology (V. Reuter) and Radiology (L. Schwartz), Memorial Sloan Kettering Cancer Center, New York, Clinical Cancer Epidemiology, Department of Oncology Pathology (G. Steineck), Karolinska Institutet, Stockholm, Sweden, Department of Medicine (W.K. Kelly, H.I. Scher), Cornell University Medical College, New York
,
Larry Schwartz From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine (G. Steineck, W.K. Kelly, R. Frank, H.I. Scher), the Departments of Pathology (V. Reuter) and Radiology (L. Schwartz), Memorial Sloan Kettering Cancer Center, New York, Clinical Cancer Epidemiology, Department of Oncology Pathology (G. Steineck), Karolinska Institutet, Stockholm, Sweden, Department of Medicine (W.K. Kelly, H.I. Scher), Cornell University Medical College, New York
&
Howard I. Scher From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine (G. Steineck, W.K. Kelly, R. Frank, H.I. Scher), the Departments of Pathology (V. Reuter) and Radiology (L. Schwartz), Memorial Sloan Kettering Cancer Center, New York, Clinical Cancer Epidemiology, Department of Oncology Pathology (G. Steineck), Karolinska Institutet, Stockholm, Sweden, Department of Medicine (W.K. Kelly, H.I. Scher), Cornell University Medical College, New York
Pages 668-674 | Published online: 08 Jul 2009

  • Scher HI, Steineck G, Kelly WK. 'Hormone-refractory' ('D3') prostate cancer refining the concept Urology 199S; 46: 142-8.
  • Sella A, Konichezky M, Flex D, Sulkes A, Baniel J. Low PSA metastatic androgen-independent prostate cancer. Eur Urol 2000; 38: 250-4.
  • di Sant'Agnese PA. Neuroendocrine differentiation in pro-static carcinoma: an update. Prostate 1998; 8 (Suppl): 74-9.
  • Jongsma J, Oomen MH, Noordzij MA, et al. Androgen-inde-pendent growth is induced by neuropeptides in human prostate cancer cell lines. Prostate 2000; 42: 34-44.
  • Bolton DM, Chiu ST, Clarke S, Angus D. Primary small cell carcinoma of the prostate: unusual modes of presentation. Aust NZ J Surg 1994; 64: 91-4.
  • Xue Y, van der LJ, Smedts F, et al. Neuroendocrine cells during human prostate development does neuroendocrine cell density remain constant during fetal as well as postnatal life? Prostate 2000; 42: 116-23.
  • Bonkhoff H. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status. Prostate 1998; 8 (Suppl): 18-22.
  • Berruti A, Dogliotti L, Mosca A, et al. Circulating neuroen-docrine markers in patients with prostate carcinoma. Cancer 2000; 88: 2590-7.
  • Aprikian AG, Cordon-Cardo C, Fair WR, et al. Neuroen-docrine differentiation in metastatic prostatic adenocar-cinoma. J Urol 1994; 151: 914-9.
  • Whelan T, Gatfleld CT, Robertson S, Carpenter B, Schillinger JF. Primary carcinoid of the prostate in conjunction with multiple endocrine neoplasia IIb in a child. J Urol 1995; 153: 1080-2.
  • Mittelman A, Shukla SK, Welvaart K, Murphy GP. Oral estramustine phosphate (NSC-89199) in the treatment of ad-vanced (stage D) carcinoma of the prostate. Cancer Chemother Rep 1975; 59: 219-23.
  • Nilsson T, Jonsson G. Clinical results with estramustine phosphate (NSC-89199): a comparison of the intravenous and oral preparations. Cancer Chemother Rep 1975; 59: 229-32.
  • Pienta KJ, Redman B, Hussain M, et al. Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate. J Clin Oncol 1994; 12: 2005-12.
  • Smith DC, Esper P, Strawderman M, Redman B, Pienta KJ. Phase II trial of oral estramustine, oral etoposide, and intra-venous paclitaxel in hormone-refractory prostate cancer. J Clin Oncol 1999; 17: 1664-71.
  • Johansson S, Steineck G, Hursti T, Fredrikson M, Furst CJ, Peterson C. Aspects of patient care. Interviews with relapse-free testicular cancer patients in Stockholm. Cancer Nurs 1992; 15: 54-60.
  • Scher HI. Management of prostate cancer after prostatec-tomy: treating the patient, not the PSA. JAMA 1999; 281: 1642-5.
  • Scher HI, Mazumdar M, Kelly WK. Clinical trials in relapsed prostate cancer: defining the target. J Natl Cancer Inst 1996; 88: 1623-34.
  • Steineck G, Kass PH, Ahlbom A. A comprehensive clinical epidemiology theory based on the concept of the source person-time and four distinct study stages. Acta Oncol 1998; 37: 15-23.
  • Dema A, Raica M, Tudose N. Prognostic significance of neuroendocrine differentiation in carcinoma of the prostate. Rom J Morphol Embryol 1996; 42: 83-8.
  • Krupski T, Petroni GR, Frierson HF Jr, Theodorescu JU. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific sur-vival following radical prostatectomy for carcinoma of the prostate. Urology 2000; 55: 743-9.
  • Steineck G, Adolfsson J, Scher HI, Whitmore Jr WF. Distin-guishing prognostic and treatment-predictive information for localized prostate cancer. Urology 1995; 45: 610-5.
  • Tannock IF, Osoba D, Stockier MR, et al. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol 1996; 14: 1756-64.
  • Tu SM, Millikan RE, Mengistu B, et al. Bone-targeted ther-apy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet 2001; 357: 336-41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.